文献速递功能神经外科

老年人群癫痫手术结局:年龄不是禁忌,时机不宜过晚

Outcomes of epilepsy surgery in the older population: not too old, not too late.
PubMed 文献 · J Neurosurg · 2021-10-08

该研究基于单中心73例50岁以上癫痫手术患者、15项回顾性研究的荟萃分析及全国行政数据库,评估老年癫痫手术的无发作率与安全性。结果显示总体无发作率73%,但死亡率和并发症率随年龄增长而升高。

要点

  • 50岁以上患者癫痫手术总体无发作率可达73%
  • 手术年龄较大与内侧颞叶硬化是无发作的重要预测因素
  • 70岁以上患者死亡率和并发症率明显升高,需权衡利弊

核心结论

  • 老年癫痫手术无发作结局良好,但随年龄增长死亡率和并发症率预期升高。

研究设计与样本

  • 单中心回顾性队列纳入2002-2018年73例50岁以上癫痫手术患者,按50-59、60-69、70+岁分组。
  • 补充文献综述与随机效应模型荟萃分析,纳入15项回顾性研究共474例。
  • 分析Vizient全国行政数据库2016-2019年并发症率、死亡率和费用数据。

主要发现

  • 本中心中位随访24个月,总体无发作率73%,50-59岁组63%,60-69岁组77%,70+岁组70%。
  • 荟萃分析合并平均随访39个月(范围6-114.8个月),合并无发作率65%(95%CI 59%-72%)。
  • 多因素荟萃回归显示,手术时平均年龄较大(系数2.1,95%CI 1.1-3.1,p<0.001)和存在内侧颞叶硬化(系数0.3,95%CI 0.1-0.6,p=0.015)是无发作的重要预测因素。

关键数值与推荐

  • 本中心队列中颞叶切除术最常见(73%),内侧颞叶硬化最常见病理(52%),其次为非特异性胶质增生(19%)。
  • Vizient数据库显示50-59、60-69、70+岁组死亡率分别为0.5%、1.1%、9.6%。
  • Vizient数据库显示50-59、60-69、70+岁组并发症率分别为7.1%、10.1%、17.3%。
  • Vizient数据库显示50-59、60-69、70+岁组平均住院费用分别为31977、34586、40153美元。

临床怎么用

  • 老年癫痫手术无发作结局良好,术前决策时应结合年龄相关死亡率和并发症率进行个体化评估与患者沟通。

局限性

  • 本中心部分年龄亚组样本量较小(50-59岁组16例,70+岁组10例)。
  • 文献部分均为回顾性研究,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The prevalence of epilepsy in the older adult population is increasing. While surgical intervention in younger patients is supported by level I evidence, the safety and efficacy of epilepsy surgery in older individuals is less well established. The aim of this study was to evaluate seizure freedom rates and surgical outcomes in older epilepsy patients. METHODS: The authors' institutional electronic database was queried for patients older than 50 who had undergone epilepsy surgery during 2002-2018. Cases were grouped into 50-59, 60-69, and 70+ years old. Seizure freedom at the last follow-up constituted the primary outcome of interest. The institutional analysis was supplemented by a literature review and meta-analysis (random effects model) of all published studies on this topic as well as by an analysis of complication rates, mortality rates, and cost data from a nationwide administrative database (Vizient Inc., years 2016-2019). RESULTS: A total of 73 patients (n = 16 for 50-59 years, n = 47 for 60-69, and n = 10 for 70+) were treated at the authors' institution. The median age was 63 years, and 66% of the patients were female. At a median follow-up of 24 months, seizure freedom was 73% for the overall cohort, 63% for the 50-59 group, 77% for the 60-69 group, and 70% for the 70+ group. The literature search identified 15 additional retrospective studies (474 cases). Temporal lobectomy was the most commonly performed procedure (73%), and mesial temporal sclerosis was the most common pathology (52%), followed by nonspecific gliosis (19%). The pooled mean follow-up was 39 months (range 6-114.8 months) with a pooled seizure freedom rate of 65% (95% CI 59%-72%). On multivariable meta-regression analysis, an older mean age at surgery (coefficient [coeff] 2.1, 95% CI 1.1-3.1, p < 0.001) and the presence of mesial temporal sclerosis (coeff 0.3, 95% CI 0.1-0.6, p = 0.015) were the most important predictors of seizure freedom. Finally, analysis of the Vizient database revealed mortality rates of 0.5%, 1.1%, and 9.6%; complication rates of 7.1%, 10.1%, and 17.3%; and mean hospital costs of $31,977, $34,586, and $40,153 for patients aged 50-59, 60-69, and 70+ years, respectively. CONCLUSIONS: While seizure-free outcomes of epilepsy surgery are excellent, there is an expected increase in morbidity and mortality with increasing age. Findings in this study on the safety and efficacy of epilepsy surgery in the older population may serve as a useful guide during preoperative decision-making and patient counseling.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Kerezoudis P, Singh R, Parisi V, et al. Outcomes of epilepsy surgery in the older population: not too old, not too late. J Neurosurg. 2021. PMID: 34624847. doi:10.3171/2021.5.JNS204211

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。